IWM vs. SBIO
IWM (iShares Russell 2000 ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - IWM is a Small Cap Blend Equities fund tracking the Russell 2000 Index, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 10 years, IWM returned 10.78%/yr vs 8.36%/yr for SBIO. A 0.68 correlation means they provide meaningful diversification when combined. IWM charges 0.19%/yr vs 0.50%/yr for SBIO.
Performance
IWM vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IWM achieves a 15.62% return, which is significantly higher than SBIO's -1.72% return. Over the past 10 years, IWM has outperformed SBIO with an annualized return of 10.78%, while SBIO has yielded a comparatively lower 8.36% annualized return.
IWM
- 1D
- 0.87%
- 1M
- -0.02%
- YTD
- 15.62%
- 6M
- 13.83%
- 1Y
- 35.52%
- 3Y*
- 16.64%
- 5Y*
- 5.48%
- 10Y*
- 10.78%
SBIO
- 1D
- -0.36%
- 1M
- -9.33%
- YTD
- -1.72%
- 6M
- -2.48%
- 1Y
- 59.38%
- 3Y*
- 16.69%
- 5Y*
- 1.33%
- 10Y*
- 8.36%
IWM vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IWM iShares Russell 2000 ETF | 15.62% | 12.66% | 11.38% | 16.83% | -20.48% | 14.54% | 20.03% | 25.39% | -11.12% | 14.58% |
SBIO ALPS Medical Breakthroughs ETF | -1.72% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between IWM and SBIO is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.67 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.69 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.68 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.68 |
The correlation between IWM and SBIO shifts across timeframes, from 0.58 (1 year) to 0.69 (5 years), reflecting how their relationship changes across market environments.
IWM vs. SBIO - Sectors Allocation Comparison
Sectors
IWM
SBIO
Technology
-
Industrials
-
Healthcare
Financial Services
Consumer Cyclical
-
Energy
-
Real Estate
-
Basic Materials
-
Utilities
-
Consumer Defensive
-
Communication Services
-
Technology
IWM
SBIO
-
Industrials
IWM
SBIO
-
Healthcare
IWM
SBIO
Financial Services
IWM
SBIO
Consumer Cyclical
IWM
SBIO
-
Energy
IWM
SBIO
-
Real Estate
IWM
SBIO
-
Basic Materials
IWM
SBIO
-
Utilities
IWM
SBIO
-
Consumer Defensive
IWM
SBIO
-
Communication Services
IWM
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IWM vs. SBIO — Risk / Return Rank
IWM
SBIO
IWM vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Russell 2000 ETF (IWM) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IWM | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | -0.30 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.33 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.24 | 4.72 | -1.48 |
| Martin ratioReturn relative to average drawdown | 11.44 | 13.54 | -2.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IWM | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.83 | 2.02 | -0.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.24 | 0.04 | +0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.25 | +0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.21 | +0.15 |
Drawdowns
IWM vs. SBIO - Drawdown Comparison
The maximum IWM drawdown since its inception was -59.05%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for IWM and SBIO.
Loading charts...
Drawdown Indicators
| IWM | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.05% | -63.06% | +4.01% |
Max Drawdown (1Y)Largest decline over 1 year | -11.03% | -12.66% | +1.63% |
Max Drawdown (3Y)Largest decline over 3 years | -27.50% | -42.44% | +14.94% |
Max Drawdown (5Y)Largest decline over 5 years | -31.91% | -53.10% | +21.19% |
Max Drawdown (10Y)Largest decline over 10 years | -41.13% | -63.06% | +21.93% |
Current DrawdownCurrent decline from peak | -2.71% | -17.90% | +15.19% |
Average DrawdownAverage peak-to-trough decline | -10.76% | -28.43% | +17.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.11% | 4.40% | -1.29% |
Volatility
IWM vs. SBIO - Volatility Comparison
The current volatility for iShares Russell 2000 ETF (IWM) is 6.52%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.87%. This indicates that IWM experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IWM | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.52% | 9.87% | -3.35% |
Volatility (6M)Calculated over the trailing 6-month period | 14.00% | 22.68% | -8.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.53% | 29.62% | -10.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.58% | 33.56% | -10.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.07% | 33.18% | -10.11% |
IWM vs. SBIO - Expense Ratio Comparison
IWM has a 0.19% expense ratio, which is lower than SBIO's 0.50% expense ratio.
Dividends
IWM vs. SBIO - Dividend Comparison
IWM's dividend yield for the trailing twelve months is around 0.89%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IWM iShares Russell 2000 ETF | 0.89% | 1.04% | 1.15% | 1.35% | 1.48% | 0.94% | 1.04% | 1.26% | 1.40% | 1.26% | 1.38% | 1.54% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Frequently Asked Questions
IWM and SBIO have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.87%) compared to IWM (6.52%). In terms of maximum drawdown, IWM dropped -59.05% vs SBIO's -63.06%.
On 10-year performance, IWM leads with 10.78% vs 8.36% for SBIO. On fees, IWM is cheaper at 0.19% per year. On volatility, IWM has been the lower-risk option at 6.52%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IWM has performed better with a 10.78% return vs 8.36%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IWM is cheaper with a 0.19% expense ratio, compared with 0.50% for SBIO.
IWM has the higher dividend yield at 0.89%, compared with 0.00% for SBIO.
IWM is categorized as Small Cap Blend Equities, while SBIO is Health & Biotech Equities. IWM tracks Russell 2000 Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: iShares and SS&C. Their fees differ too: 0.19% for IWM and 0.50% for SBIO.
SBIO currently has the higher Sharpe Ratio (2.02 vs 1.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IWM and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer